BACKGROUND: Progress has been made in addressing pain in specific diseases such as cancer, but less attention has focused on understanding pain in nonmalignant states, including heart failure (HF). METHODS AND RESULTS: From March 2006 to June 2007, 672 veterans were surveyed and scores for the Brief Pain Inventory, pain distress, clinically significant pain levels (moderate to severe pain), and pain locations were compared using univariate and multivariate models. Fifteen percent of the final sample had HF (95/634). In our study, the HF patients were older (P < .000), reported lower levels of general health (P = .018), had more co-morbidities (P < .000), were more likely to have a history of cancer (P = .035), and suffered more chest pain and fewer headaches (P = .026, P = .03, respectively) than their non-HF cohorts. When controlling for age, co-morbidity and cancer disorders, HF and non-HF patients did not differ in pain severity, interference, distress or locations. Of the patients currently experiencing pain, 67.3% of HF patients and 68.4% of non-HF patients rated their pain as moderate or severe (pain >or=4 on a 0 to 10 scale). CONCLUSIONS: Although HF has not been identified as a painful condition, this study suggests the burden of pain is significant for both HF and non-HF ambulatory care patients.
BACKGROUND: Progress has been made in addressing pain in specific diseases such as cancer, but less attention has focused on understanding pain in nonmalignant states, including heart failure (HF). METHODS AND RESULTS: From March 2006 to June 2007, 672 veterans were surveyed and scores for the Brief Pain Inventory, pain distress, clinically significant pain levels (moderate to severe pain), and pain locations were compared using univariate and multivariate models. Fifteen percent of the final sample had HF (95/634). In our study, the HF patients were older (P < .000), reported lower levels of general health (P = .018), had more co-morbidities (P < .000), were more likely to have a history of cancer (P = .035), and suffered more chest pain and fewer headaches (P = .026, P = .03, respectively) than their non-HF cohorts. When controlling for age, co-morbidity and cancer disorders, HF and non-HF patients did not differ in pain severity, interference, distress or locations. Of the patients currently experiencing pain, 67.3% of HF patients and 68.4% of non-HF patients rated their pain as moderate or severe (pain >or=4 on a 0 to 10 scale). CONCLUSIONS: Although HF has not been identified as a painful condition, this study suggests the burden of pain is significant for both HF and non-HF ambulatory care patients.
Authors: Herbert C Szeto; Robert K Coleman; Parisa Gholami; Brian B Hoffman; Mary K Goldstein Journal: Am J Manag Care Date: 2002-01 Impact factor: 2.229
Authors: Vincent S Fan; David Au; Patrick Heagerty; Richard A Deyo; Mary B McDonell; Stephan D Fihn Journal: J Clin Epidemiol Date: 2002-04 Impact factor: 6.437
Authors: Himali Weerahandi; Nathan Goldstein; Laura P Gelfman; Ulrich Jorde; James N Kirkpatrick; Judith Marble; Yoshifumi Naka; Sean Pinney; Mark S Slaughter; Emilia Bagiella; Deborah D Ascheim Journal: J Pain Symptom Manage Date: 2016-07-09 Impact factor: 3.612
Authors: Lisa Zubkoff; Karl A Lorenz; Andy B Lanto; Cathy D Sherbourne; Joy R Goebel; Peter A Glassman; Lisa R Shugarman; Lisa S Meredith; Steven M Asch Journal: J Gen Intern Med Date: 2010-03-14 Impact factor: 5.128
Authors: Joy R Goebel; Lynn V Doering; Karl A Lorenz; Sally L Maliski; Adeline M Nyamathi; Lorraine S Evangelista Journal: Nurs Forum Date: 2009 Jul-Sep
Authors: Joy R Goebel; Lynn V Doering; Lisa R Shugarman; Steve M Asch; Cathy D Sherbourne; Andy B Lanto; Lorraine S Evangelista; Adeline M Nyamathi; Sally L Maliski; Karl A Lorenz Journal: J Pain Symptom Manage Date: 2009-09-03 Impact factor: 3.612
Authors: Rachel Wells; Macy L Stockdill; J Nicholas Dionne-Odom; Deborah Ejem; Kathryn L Burgio; Raegan W Durant; Sally Engler; Andres Azuero; Salpy V Pamboukian; Jose Tallaj; Keith M Swetz; Elizabeth Kvale; Rodney O Tucker; Marie Bakitas Journal: Trials Date: 2018-08-06 Impact factor: 2.279